NCT04607785

Brief Summary

Gingivitis is a form of gum disease and is elicited by the accumulation of plaque on the tooth and the soft-tissue adjoining the tooth. Mouthwashes containing chemical or herbal substances are adjunctive tools in improving oral hygiene. Miswak mouthwash is a herbal mouthwash. Chlorhexidine mouthwash is the most efficient antimicrobial and antiplaque agent. The aim of the study is to assess the effectiveness of the miswak mouthwash with 0.12% chlorhexidine. This study was a blind randomized clinical trial. Materials and Methods: A total of 60 patients aged (20-55) years old who attended the Periodontics Clinics at College of Dentistry, Al-Iraqia University were allocated for use the mouthwash either miswak mouthwash or 0.12% chlorhexidine gluconate Kin Gingival® (Laboratorios KIN, Spain) twice daily (once in the morning and one before bedtime) for seven days. Gingival, bleeding, and plaque indices were recorded at baseline and after 7 days of treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Jan 2020

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2020

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 9, 2020

Completed
20 days until next milestone

First Posted

Study publicly available on registry

October 29, 2020

Completed
Last Updated

November 3, 2020

Status Verified

October 1, 2020

Enrollment Period

2 months

First QC Date

October 9, 2020

Last Update Submit

October 31, 2020

Conditions

Keywords

Miswakchlorhexidinemouthwashgingivitisoral health

Outcome Measures

Primary Outcomes (3)

  • Inflammation of gingiva

    Change in Gingival index

    2 months

  • Bleeding from gingiva

    Change in index

    2 months

  • Plaque in the gingiva

    Change in index

    2 months

Study Arms (2)

Miswak mouthwash group

ACTIVE COMPARATOR

Miswak sticks were bought from local markets, Baghdad, Iraq, washed with cold water and dried then crushed into powder. Later,7 grams of the miswak powder weighted and added to 350 ml of distilled water (D.W.) in a conical flask for 24 hours. Finally, the solution then filtered and stored in tightly closed bottles in a cool place.9

Drug: Miswak mouthwash groupDevice: Chlorhexidine gluconate mouthwash

Chlorhexidine mouthwash group

OTHER

0.12% chlorhexidine gluconate mouthwash for seven days

Drug: Miswak mouthwash groupDevice: Chlorhexidine gluconate mouthwash

Interventions

Twice daily for seven days for two months

Chlorhexidine mouthwash groupMiswak mouthwash group

Twice daily for seven days for two months

Also known as: chlorhexidine gluconate Kin Gingival®
Chlorhexidine mouthwash groupMiswak mouthwash group

Eligibility Criteria

Age20 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adults with existence at least 20 natural teeth in the mouth
  • Existence of lateral maxillary teeth
  • Existence of central teeth
  • Existence of mandibular teeth

You may not qualify if:

  • Patients have no history of drug use
  • Patients have no any disease relevant occurrence
  • Pocket depth\<3 mm
  • Smokers
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dunia Wadeea Sabea

Baghdad, 10001, Iraq

Location

MeSH Terms

Conditions

Gingivitis

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 9, 2020

First Posted

October 29, 2020

Study Start

January 15, 2020

Primary Completion

March 15, 2020

Study Completion

March 15, 2020

Last Updated

November 3, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

No need

Locations